Rising MRSA superbug infections among fitness enthusiasts in the US and UK: Risks and prevention
UKHSA
) and a study published in
NIH
has raised a red flag about the rising spread of MRSA superbugs in community settings, particularly in gyms, health clubs, and other shared fitness spaces.
MRSA, or Methicillin-resistant Staphylococcus aureus, is a type of bacteria resistant to many antibiotics, making it difficult to treat and potentially dangerous.
What's especially alarming is that even healthy, active individuals are at risk. MRSA can survive on shared equipment, locker room benches, gym mats, towels, and other high-touch surfaces. Combine that with sweat, skin-to-skin contact, and poor cleaning practices, and you've got a perfect breeding ground for infection.
The report shows a notable rise in MRSA cases among people under 45, many of whom regularly visit fitness centers.
This surge in community-associated MRSA infections is a wake-up call for gym-goers to prioritize hygiene. Simple steps like wiping down equipment, using personal towels, wearing footwear in locker rooms, and avoiding direct contact with shared surfaces can go a long way in protecting yourself and others.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Mr. Bala's Powerful Intraday Strategy Revealed – No More Guesswork
TradeWise
Learn More
Undo
Fitness should strengthen you, not expose you to unnecessary health risks.
Understanding MRSA superbugs and their impact on fitness enthusiasts
Superbugs, or antibiotic-resistant bacteria, are a growing public health concern. These bacteria have evolved to withstand multiple antibiotics, making infections increasingly difficult to treat. One environment that can unknowingly contribute to the spread of these dangerous microbes is the fitness center. Gyms are communal spaces where people frequently share equipment, come into close physical contact, and perspire heavily, all of which create ideal conditions for bacterial transmission.
One of the most well-known superbugs, MRSA (methicillin-resistant Staphylococcus aureus), is commonly found on skin and can spread through contaminated surfaces. When gym-goers fail to clean machines or mats after use, bacteria can easily transfer from person to person. Even small cuts or abrasions, common during workouts, can become entry points for these infections.
Adding to the risk, bacteria like MRSA can survive for days on surfaces such as dumbbells, benches, and yoga mats.
Moist environments like locker rooms and showers also promote bacterial growth, further increasing the chances of exposure.
Preventing the spread of superbugs in gyms requires shared responsibility. Fitness centers should regularly disinfect equipment and facilities, and provide hand sanitizers and cleaning supplies. Gym members should also practice good hygiene, washing hands, wiping down machines, using towels as barriers, and avoiding workouts if they have open wounds or skin infections.
As superbugs become more resistant to treatments, it's crucial to limit their spread in everyday environments like gyms.
A clean, mindful workout space helps protect everyone's health.
Key findings from recent studies on MRSA superbugs
Study 1: A study conducted in the Memphis metropolitan area by
NIH
, found a high prevalence of multi-drug-resistant MRSA strains on surfaces in fitness centers. The research underscores the role of inanimate surfaces as potential sources of transmission.
Study 2: Research from the
UK Health Security Agency
indicates a rise in community-associated MRSA infections, particularly among individuals under 45, many of whom are active in sports and fitness activities.
Preventive measures and recommendations for
MRSA superbug infections
To effectively reduce the risk of superbug infections in fitness centers and other shared environments, health experts advise taking a proactive approach to hygiene and safety. The following measures are essential for both gym-goers and facility operators:
Regularly disinfect gym equipment: All shared equipment, including weights, treadmills, benches, yoga mats, and exercise balls should be thoroughly cleaned with approved disinfectant wipes or sprays both before and after use. This helps eliminate harmful bacteria that may linger on surfaces for hours or even days.Avoid sharing personal items: Items such as towels, water bottles, razors, and clothing should never be shared. These can easily harbor and transfer bacteria from one person to another, especially in warm and humid gym environments.
Cover all cuts, wounds, or abrasions: Open skin, even small nicks or blisters, can serve as entry points for bacteria like MRSA. Always use clean, waterproof bandages and avoid exposing broken skin to shared equipment or surfaces.
Practice consistent personal hygiene: Wash your hands thoroughly with soap and water before and after workouts. If handwashing isn't possible, use an alcohol-based hand sanitizer. Shower promptly after exercising, especially if you've used communal areas like locker rooms, saunas, or pools.
Wear proper footwear: Always wear flip-flops or shower shoes in communal showers and locker rooms to prevent contact with bacteria on wet surfaces.
Report and avoid unsanitary conditions: If gym facilities appear unclean or lack proper sanitization supplies, inform staff or consider using a different location.
While the rise of superbug infections is undoubtedly concerning, it is not a cause for panic but rather a call to action.
By adopting proper hygiene practices, being mindful of personal and shared cleanliness, and remaining vigilant in fitness environments, individuals can play a key role in minimizing the spread of antibiotic-resistant bacteria.
Simple actions like disinfecting equipment, covering wounds, and washing hands can make a significant difference. Fitness enthusiasts are encouraged to stay informed, take personal responsibility, and contribute to a safer, healthier gym experience for everyone. Proactive prevention today can help protect our health tomorrow.
Also read|
When being too healthy becomes unhealthy: 3 daily habits that can damage your body long-term
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Riding high on Wegovy, Novo Nordisk doubled its workforce. Now layoffs loom
As Novo Nordisk 's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that almost doubled staff numbers over five years. Now sales are slowing and layoffs loom. Annual reports show that Novo's workforce grew from around 43,260 employees in 2019 to 77,350 by the end of last year - an average of 131 new roles filled each week, far faster than rival Eli Lilly, whose headcount rose from 36,000 to 47,000 over the same period. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Skin Issues? See What An Online Dermatologist Should Cost In Rawabadak Selatan AskLayers Learn More Undo Novo's rapid expansion is now under scrutiny from investors and even management, with the drugmaker facing cost pressure and heightened competition from Lilly's Zepbound and cheaper weight loss copycat compounds in the United States. "I don't want to limit myself in terms of where I look for savings, and salaries are a cost item. I will go through everything," said CEO Maziar Mike Doustdar on August 7, his first day in the job. Two weeks later, on Wednesday, Novo said it had implemented a global hiring freeze for non-critical roles. Live Events When asked for details of headcount reduction plans, a company spokesperson referred Reuters to Doustdar's comments. The five-year hiring surge saw employee costs almost double to nearly $9.9 billion by last year, company filings show. While the increased overhead barely registered as sales shot up, Novo's gross margin has been squeezed this year, reaching its lowest level in two and a half years in the second quarter. The stock market has wiped $490 billion off the company's market capitalisation since a peak last year when it was Europe's most valuable firm. It appointed Doustdar to turn things around after twice warning on profit this year and saying sales could dip in the second half of 2025 from a year earlier. "Their earnings had been so strong that you could ignore the cost side," said Lars Hytting, head of trading at Denmark-based investment firm ArthaScope, which holds Novo shares, adding the firm had grown "complacent" and now needed to slim down. "Novo is now going on Wegovy." SALES JOBS SEEN AT RISK Some analysts anticipate layoffs in the sales division - a common industry cost-cutting measure. Novo hinted at this during its second-quarter results, saying it would begin deprioritising sales of Rybelsus, its older type 2 diabetes treatment. Sales of the drug have declined, eclipsed by soaring demand for Ozempic, which shares the same active ingredient as Wegovy. "That is probably not a coincidence," said TD Cowen analyst Michael Nedelcovych. "When companies try to cut costs, they probably look first to a sales force for an ailing drug." Novo built a new U.S. sales force to market Wegovy to doctors rather than rely on staff who were already promoting Ozempic, three former employees familiar with the drug's launch told Reuters. That meant more costs, and at times the teams overlapped in outreach to the same healthcare providers, they said. All asked not to be named in order to speak frankly about a former employer. The Novo Nordisk spokesperson declined to comment on the structure of its business. In response to the initial unprecedented demand for Wegovy, Novo also invested billions to expand factories in Denmark and the United States. The company said in early 2024 that around 70% of new hires in the previous two to three years were in the manufacturing division. The spokesperson said that last year, 49% of new hires were related to manufacturing, including around 3,200 employees from Catalent, a contract drugmaker acquired last year by Novo Holdings, Novo Nordisk's controlling shareholder. Novo could also first turn to functions such as communications or administrative roles for cuts, because reductions in sales or manufacturing could hinder its ability to regain market share, said Simon Birkso Larsen, founder and head of Pipeline Clarity, a Copenhagen-based pharmaceutical industry consultancy that does not count Novo as a client. Larsen was a Novo Nordisk employee from 2015 to 2017. "Novo hired so rapidly that it has become difficult to figure out who does what in the are limits to how many people you can integrate and still be effective," he said.
Time of India
an hour ago
- Time of India
Liver Cirrhosis risk? Check your nails, this common condition might be telling you something
They say our body speaks in signals, but sometimes it does so in whispers too faint to notice. Nails, often overlooked as mere cosmetic features, can act as surprising messengers of our internal health. Among these subtle signs lies a condition known as Terry's nails, which, as reported in TOI, could be an early warning of liver cirrhosis . Terry's nails are a nail abnormality where the nail bed turns white with a 'frosted' look, leaving only a thin reddish-brown or pink strip at the very tip. This change, first described in 1954, isn't just about appearances, it's strongly linked to serious health conditions. Liver cirrhosis is the most common association, but these nails may also show up in people with heart failure, diabetes, or kidney disease. Simply put, your fingertips may be hinting at an underlying battle your organs are fighting. Who Was Dr Richard Terry? Dr Richard Terry, a British physician, first identified this peculiar nail sign. He served as a medical officer in the Royal Army Medical Corps during World War II and went on to contribute significantly to internal medicine. Sadly, he passed away on his 46th birthday, but his legacy continues through his medical observations, particularly the condition now known as Terry's nails. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The 20 Most Beautiful Female Celebrities in the World Trips-Shop Undo In his own words, as cited in TOI, he described the nails as 'fully developed white nails' with a ground-glass opacity stretching almost the entire nail bed, sparing only a small pink band at the edge. He noticed it most prominently in thumbs and forefingers, and always in both hands. TOI notes that Dr Terry studied this nail pattern in 82 out of 100 consecutive patients with hepatic cirrhosis, over 90% of whom had alcohol-related cirrhosis. A few months later, he also observed it in patients with congestive heart failure. His work laid the foundation for recognising nails as a non-invasive diagnostic clue in internal medicine. Live Events What Does Research Say? Recent studies back up Dr Terry's observations. A large study titled 'Association of Terry's Nails with Liver Cirrhosis' assessed 1,000 patients between 2016 and 2020. As per TOI, 117 of them were found to have Terry's nails. Among patients already diagnosed with cirrhosis, about 25.6% displayed this nail sign, with cirrhosis emerging as the strongest correlate after adjusting for age, diabetes, and heart failure. Researchers concluded that while not definitive, Terry's nails can serve as a useful clinical clue in primary care. How to Spot Terry's Nails According to TOI, you might notice these features if you have Terry's nails: A pale, white, ground-glass appearance covering most of the nail Absence of the lunula (the half-moon at the nail base) A narrow reddish-brown band at the tip Symmetry, the condition usually affects both hands equally Terry's nails are not a disease in themselves, but a sign of deeper health issues. If you notice such nail changes, especially alongside symptoms like chronic fatigue, unexplained weight loss, weakness, or conditions such as heart failure, diabetes, or kidney disease, it's wise to seek medical advice. Your nails may seem like the least important part of your body, but sometimes they are the most honest storytellers. Inputs from TOI
Time of India
an hour ago
- Time of India
Expand AYUSH-based services to promote integrative oncology approaches: Parliamentary panel
A parliamentary committee has recommended taking proactive steps to expand the institutional footprint of AYUSH-based healthcare services across the country to promote integrative oncology approaches and enable patients to benefit from diverse therapeutic options rooted in India's traditional knowledge systems for combating cancer. Headed by Narain Dass Gupta, the Committee on Petitions of the Rajya Sabha noted in its 163rd report presented on Wednesday that the penetration of alternative systems of medicine -- namely Ayurveda, Homeopathy, Unani and Siddha -- within the domain of cancer care remains significantly limited in comparison to allopathic treatment modalities. The Ministry of AYUSH has reported ongoing advancements in cancer-related research across these traditional systems. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What Happens When You Massage Baking Soda Into Your Scalp Read More Undo It also recommended the establishment of dedicated institutions for AYUSH-based cancer care in every state and Union Territory (UT), modelled on the All India Institute of Ayurveda, New Delhi. "Such a move would broaden access, promote integrative oncology approaches and enable patients to benefit from diverse therapeutic options rooted in India's traditional knowledge systems," the panel said. Live Events The Committee further recommended that cancer be declared a notifiable disease across all states and UTs. It said reliable data is vital for assessing public health issues, particularly cancer, where comprehensive information is essential to track trends, design policies and plan infrastructure. At present, cancer data is primarily drawn from the National Cancer Registry Programme (NCRP), which covers only about 18 per cent of the population, which is insufficient for a national picture. Healthcare professionals have long advocated for declaring cancer a notifiable disease. At present, the government's position is guided by WHO norms, which limit notification to communicable diseases. "However, given the rising cancer burden in India, this stance warrants a serious reconsideration. Given India's rising cancer burden, the Committee is of the view that declaring cancer notifiable would ensure systematic reporting, generate real-time and credible data, strengthen surveillance and enable evidence-based policymaking. "It would support targeted interventions, rational resource allocation, region-specific strategies and development of appropriate infrastructure," it said in the report. While some states have already made cancer notifiable, a national mandate would ensure uniform documentation and a clear picture of the disease burden. The Committee also noted that while banks, PSUs and corporates invest substantially in corporate social responsibility (CSR) largely in healthcare, education and women's empowerment, these efforts are often compliance-driven and concentrated around operational areas. It, therefore, recommended that a defined share of CSR funds be earmarked for cancer care to complement government efforts, particularly by establishing diagnostic centres, radiotherapy units and palliative care facilities in underserved and rural regions. Corporates should realign CSR strategies with national health priorities, shifting to a needs-based outcome-driven model that meaningfully addresses gaps in the cancer care ecosystem and contributes to inclusive nation-building, the panel said. Patient Assistance Programmes are a commendable initiative by the government aimed at ensuring access to affordable medicines, particularly for economically vulnerable sections of society, the panel noted. Programmes such as the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) play a critical role in providing low-cost medicines to patients from low-income groups. It noted that while some pharmaceutical companies do offer patient support programmes, their presence remains limited. It recommended engaging more pharmaceutical manufacturers to implement such initiatives, particularly in areas where access to healthcare services is inadequate. "This would greatly enhance the accessibility and affordability of essential treatments for disadvantaged populations. The Patient Assistance Programmes must also educate the patients about the treatment methodologies available and ensure that they adhere to the treatment plan. "They should also be educated about the different government schemes available," the panel recommended.
